Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Ferrante

Showing results (191-200 of 246) with videos related to

Pageof 25
Sort By:
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1995
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivoJ B Schulz, R T Matthews, B G Jenkins, et al.
Neurology|March 13, 2002
Regional and progressive thinning of the cortical ribbon in Huntington's diseaseH D Rosas, A K Liu, S Hersch, et al.
Neurobiology of Disease|February 15, 2003
Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expressionOle A Andreassen, Alpaslan Dedeoglu, Violeta Stanojevic, et al.
The Journal of Biological Chemistry|October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's diseaseGabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Journal of Neurochemistry|June 7, 2005
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis miceHoon Ryu, Karen Smith, Sandra I Camelo, et al.
Biochimica Et Biophysica Acta|December 21, 2005
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease miceEdward C Stack, Karen M Smith, Hoon Ryu, et al.
Journal of Neurochemistry|September 13, 2003
Depletion of wild-type huntingtin in mouse models of neurologic diseasesYu Zhang, Mingwei Li, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease miceRobert J Ferrante, James K Kubilus, Junghee Lee, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Interpretable representation learning for 3D multi-piece intracellular structures using point cloudsRitvik Vasan, Alexandra J Ferrante, Antoine Borensztejn, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in miceA Rakhit, M M Yeon, J Ferrante, et al.
Pageof 25

Showing results (191-200 of 246) with videos related to

Sort By:
Pageof 25
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 1, 1995
Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivoJ B Schulz, R T Matthews, B G Jenkins, et al.
Neurology|March 13, 2002
Regional and progressive thinning of the cortical ribbon in Huntington's diseaseH D Rosas, A K Liu, S Hersch, et al.
Neurobiology of Disease|February 15, 2003
Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expressionOle A Andreassen, Alpaslan Dedeoglu, Violeta Stanojevic, et al.
The Journal of Biological Chemistry|October 21, 2004
Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's diseaseGabriella Gardian, Susan E Browne, Dong-Kug Choi, et al.
Journal of Neurochemistry|June 7, 2005
Sodium phenylbutyrate prolongs survival and regulates expression of anti-apoptotic genes in transgenic amyotrophic lateral sclerosis miceHoon Ryu, Karen Smith, Sandra I Camelo, et al.
Biochimica Et Biophysica Acta|December 21, 2005
Combination therapy using minocycline and coenzyme Q10 in R6/2 transgenic Huntington's disease miceEdward C Stack, Karen M Smith, Hoon Ryu, et al.
Journal of Neurochemistry|September 13, 2003
Depletion of wild-type huntingtin in mouse models of neurologic diseasesYu Zhang, Mingwei Li, Martin Drozda, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 17, 2003
Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease miceRobert J Ferrante, James K Kubilus, Junghee Lee, et al.
Biorxiv : the Preprint Server for Biology|August 2, 2024
Interpretable representation learning for 3D multi-piece intracellular structures using point cloudsRitvik Vasan, Alexandra J Ferrante, Antoine Borensztejn, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Down-regulation of the pharmacokinetic-pharmacodynamic response to interleukin-12 during long-term administration to patients with renal cell carcinoma and evaluation of the mechanism of this "adaptive response" in miceA Rakhit, M M Yeon, J Ferrante, et al.
Pageof 25